Bridge anticoagulant neutralizing agent

increases markedly the level of circulating Factor VIII when infused with Factor VIII into hemophilic subject; obtained from donor plasma; clinical trials on material is planned; no other info available

Also Known As:

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Neoplasms (Cancer) 01/01/1988 - "Amonafide, one of a series of imide derivatives of 1,8-naphthalic acid synthesized by Brana et al. has shown significant antitumor activity against a variety of experimental tumors, including L1210 leukemia and P388 leukemia. "
2.	Leukemia P388 01/01/1988 - "Amonafide, one of a series of imide derivatives of 1,8-naphthalic acid synthesized by Brana et al. has shown significant antitumor activity against a variety of experimental tumors, including L1210 leukemia and P388 leukemia. "
3.	Leukemia L1210 01/01/1988 - "Amonafide, one of a series of imide derivatives of 1,8-naphthalic acid synthesized by Brana et al. has shown significant antitumor activity against a variety of experimental tumors, including L1210 leukemia and P388 leukemia. "

Related Drugs and Biologics

1.	Imides
2.	1,8-naphthalenedicarboxylic acid
3.	amonafide